KUALA LUMPUR (Reuters) – Malaysia’s health ministry said on Tuesday it has granted conditional approval for emergency use to the single dose COVID-19 vaccines manufactured by China’s CanSino Biologics and U.S. drugmaker Johnson&Johnson.
It has also approved the use of the Pfizer-BioNTech vaccine for recipients aged 12 and above, the ministry said in a statement.
(Reporting by Rozanna Latiff; Editing by Ed Davies)
